Guardian Pharmacy Services (NYSE:GRDN) Given New $24.00 Price Target at Truist Financial

Guardian Pharmacy Services (NYSE:GRDN) had its target price increased by Truist Financial from $22.00 to $24.00 in a research report report published on Friday,Benzinga reports. The firm currently has a buy rating on the stock.

Several other analysts have also recently weighed in on GRDN. Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price objective on the stock. Raymond James began coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 price target on the stock.

Guardian Pharmacy Services Price Performance

Shares of GRDN stock opened at $21.34 on Friday. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19). The business had revenue of $314.39 million during the quarter, compared to analysts’ expectations of $303.21 million. As a group, analysts expect that Guardian Pharmacy Services will post 0.81 EPS for the current year.

Insider Activity at Guardian Pharmacy Services

In related news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the stock in a transaction dated Friday, September 27th. The stock was bought at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the transaction, the director now directly owns 35,714 shares of the company’s stock, valued at approximately $499,996. The trade was a ? increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Institutional Trading of Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Wellington Management Group LLP bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at about $8,400,000. Allspring Global Investments Holdings LLC bought a new position in Guardian Pharmacy Services during the third quarter worth about $5,460,000. Maven Securities LTD acquired a new position in Guardian Pharmacy Services during the third quarter worth approximately $3,033,000. Seven Grand Managers LLC bought a new stake in Guardian Pharmacy Services in the third quarter valued at approximately $2,515,000. Finally, Foundry Partners LLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at approximately $1,680,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.